AXONICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.09 USD | -0.06% |
|
-0.19% | +7.81% |
| May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
| May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical Devices & Implants
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.42B | - | |||||
| 130B | ||||||
| 10.99B | ||||||
| 8.35B | ||||||
| 5.67B | - | |||||
| 4.72B |
- Stock Market
- Equities
- AXNX Stock
- Charts Axonics, Inc.
- Sector Chart
